First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

A person in Missouri who didn’t report any contact with animals has tested positive for H5 bird flu, the state’s Department ...

Private equity firms are leading the buyout of R1 RCM, a major provider of billing and administrative services for hospitals ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Anyway, we ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with ...

PREVENT, its creators acknowledge, is an experiment. If it can retain accuracy in predicting heart disease risk without using ...

We have each worked on childhood vaccination programs in both development and humanitarian emergency settings for more than ...

Voters deserve to know the answers to these questions, and moderators need to ask. Mary Giliberti is the chief public policy ...

FDA staffers have not returned to roughly 2,000 pharmaceutical manufacturing firms to conduct surveillance inspections since ...

Trying to time your seasonal vaccines just right? There are no easy answers, but here are some factors to consider.

STAT's The Readout Loud covers an upcoming presentation from Summit Therapeutics, mixed data from Recursion, and amylin ...